The Department of Health and Social Care (DH) has issued a medicine supply notification (MSN) for Irbesartan 150mg and hydrochlorothiazide 12.5mg tablets.
According to the MSN, Irbesartan 150mg and hydrochlorothiazide 12.5mg tablets will remain out of stock until early May 2021.
“Irbesartan/hydrochlorothiazide 300mg/25mg tablets are unscored oval shaped tablets and not suitable for halving. Of the separate components, only irbesartan 150mg tablets are available (hydrochlorothiazide tablets were discontinued many years ago) and can support any uplift in demand,” the DH said in an update on Friday (March 19).
An alternative thiazide diuretic, bendroflumethiazide 2.5mg, is available and can support any spike in demand.
“A switch to separate components but using bendroflumethiazide in place of hydrochlorothiazide, is an option for patients who run out of irbesartan/hydrochlorothiazide 150mg/12.5mg tablets,” the MSN said.